1 Min Read
Nov 2 (Reuters) - Lonza Group Ag
* Says expands service offerings for early phase biopharmaceutical drug development Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.